Articles From: Pharmagen Enters into Financial Advisory Agreement with Merriman Capital, Inc. to PHI, Inc. Announces Results for the First Quarter Ended March 31, 2013


2013/3/4
SILVER SPRING, Md.
Sign-up for Pharmagen Enters into Financial Advisory Agreement with Merriman Capital, Inc. investment picks
2013/4/10
SILVER SPRING, Md.
Sign-up for Pharmagen Laboratories Remains Industry Leader on Patient Safety investment picks
2013/4/4
SILVER SPRING, Md.
Sign-up for Pharmagen Presents to North Carolina General Assembly at N.C. Bio's Legislative Breakfast investment picks
2013/5/8
ANNAPOLIS, Md.
Sign-up for PharmAthene Reports First Quarter 2013 Financial And Operational Results investment picks
2013/3/13
ANNAPOLIS, Md.
Sign-up for PharmAthene Reports Year-End 2012 Financial And Operational Results investment picks
2013/5/6
ANNAPOLIS, Md.
Sign-up for PharmAthene To Host First Quarter 2013 Conference Call And Webcast On Wednesday, May 8, 2013 investment picks
2013/3/12
ANNAPOLIS, Md.
Sign-up for PharmAthene To Host Year-End 2012 Conference Call And Webcast On Wednesday, March 13, 2013 investment picks
2013/3/12
PharMerica Corporation (NYSE: PMC) , a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that the Company’s annual meeting of shareholders will be held on Tuesday, June 18, 2013, in Louisville, Kentucky.
Sign-up for PharMerica Announces Date of 2013 Annual Shareholders’ Meeting investment picks
2013/4/12
PharMerica Corporation (NYSE: PMC) , a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that the Company has appointed David W.
Sign-up for PharMerica Appoints David Froesel, Jr. as Interim Chief Financial Officer investment picks
2013/4/2
PharMerica Corporation (NYSE: PMC) announced today that it will provide an online simulcast of its first quarter 2013 earnings conference call on Thursday, May 2, 2013.
Sign-up for PharMerica Corporation to Broadcast First Quarter 2013 Results Conference Call Live on the Internet investment picks
2013/5/1
PharMerica Corporation (NYSE: PMC) , a national provider of pharmacy services, today reported its financial results for the first quarter of 2013.
Sign-up for PharMerica Reports Results for the First Quarter of 2013 investment picks
2013/2/7
PharMerica Corporation (NYSE: PMC) , a national provider of institutional pharmacy, specialty infusion services, and hospital pharmacy management services, today reported its financial results for the fourth quarter of 2012 and year ended December 31, 2012.
Sign-up for PharMerica Reports Results for the Fourth Quarter of 2012 and Year Ended December 31, 2012 investment picks
2013/3/7
PharMerica Corporation (NYSE: PMC) , a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that Michael J.
Sign-up for PharMerica to Present at the Barclays Global Healthcare Conference investment picks
2013/2/19
PharMerica Corporation (NYSE: PMC) , a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that Michael J.
Sign-up for PharMerica to Present at the Citi 2013 Global Healthcare Conference investment picks
2013/2/27
PharMerica Corporation (NYSE: PMC) , a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that Michael J.
Sign-up for PharMerica to Present at the Cowen and Company 33rd Annual Health Care Conference investment picks
2013/2/6
PharMerica Corporation (NYSE: PMC) , a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that Michael J.
Sign-up for PharMerica to Present at the Leerink Swann Global Healthcare 2013 Conference investment picks
2013/2/20
PharMerica Corporation (NYSE: PMC) , a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that Michael J.
Sign-up for PharMerica to Present at the RBC Capital Markets 2013 Healthcare Conference investment picks
2013/4/29
CHICAGO, April 29, 2013 (GLOBE NEWSWIRE) -- Durata Therapeutics , Inc. (Nasdaq:DRTX) today announced data from a Phase 1 study of its lead product candidate, dalbavancin, under investigation for the treatment of susceptible gram positive bacterial infections including MRSA.
Sign-up for Phase I Data Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Weekly Doses of Dalbavancin Presented at the 23rd Annual ECCMID Meeting investment picks
2013/4/8
-Nine Ibrutinib Presentations at the American Association of Cancer Research - SUNNYVALE, Calif.
Sign-up for Phase II Ibrutinib Monotherapy Study Shows CLL Patients Achieved Rapid and Sustainable Disease Control Irrespective of Age or High Risk Prognostic Factor investment picks
2013/3/4
Teva Pharmaceutical Industries Ltd.
Sign-up for Phase III Study of Teva’s Milprosa™ (Progesterone) Vaginal Ring Published in Fertility and Sterility investment picks
2013/4/22
PHAZAR CORP, (NASDAQ: ANTP) designs, manufactures and markets antennas, towers, support structures, masts and communication accessories worldwide.
Sign-up for PHAZAR CORP Reports Third Quarter Fiscal 2013 Financial Results investment picks
2013/3/7
PHD Virtual Technologies, a pioneer in virtual machine backup and recovery , and innovator of virtualization monitoring solutions , announced today that it has raised $4 million recently with $2 Million in Series C funding led by Insight Venture Partners and Citrix (NASDAQ: CTXS) , both current investors in the company, and a $2 million venture debt financing from Wellington Financial.
Sign-up for PHD Virtual Raises $4 Million investment picks
2013/5/1
PHH Corporation (NYSE: PHH) (“PHH” or the “Company”) today announced financial results for the quarter ended March 31, 2013.
Sign-up for PHH Corporation Announces First Quarter 2013 Results investment picks
2013/2/6
PHH Corporation (NYSE: PHH) (“PHH” or the “Company”) today announced financial results for the quarter and year ended December 31, 2012.
Sign-up for PHH Corporation Announces Fourth Quarter and Full-Year 2012 Results investment picks
2013/2/19
http://media.marketwire.com/attachments/201102/20088_PHIGroupInc..jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=987186&ProfileId=051205&sourceType=1 LOS ANGELES, CA and JAKARTA, INDONESIA --
Sign-up for PHI Group Engages Runge to Conduct Technical Due Diligence of PT TSA Coal Concessions in Indonesia investment picks
2013/3/27
http://media.marketwire.com/attachments/201102/20088_PHIGroupInc..jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1001340&ProfileId=051205&sourceType=1 LOS ANGELES, CA and JAKARTA, INDONESIA --
Sign-up for PHI Group Provides Corporate Updates investment picks
2013/1/30
http://media.marketwire.com/attachments/201102/20088_PHIGroupInc..jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=979985&ProfileId=051205&sourceType=1 SINGAPORE and HANOI, VIETNAM --
Sign-up for PHI Group's Chairman and CEO Henry Fahman Speaks at the 11th Annual Coal Markets Conference in Singapore investment picks
2013/5/3
PHI, Inc. (The Nasdaq Global Market: PHII (voting) PHIIK (non-voting)) today reported financial results for the quarter ended March 31, 2013.
Sign-up for PHI, Inc. Announces Results for the First Quarter Ended March 31, 2013 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Pharmagen Enters into Financial Advisory Agreement with Merriman Capital, Inc. to PHI, Inc. Announces Results for the First Quarter Ended March 31, 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity